Advances in PH Journal
The Fifth World Symposium on Pulmonary Hypertension: Application to Practice, Spring 2014 (Vol 13, No 1)
- Spring 2014 (Vol 13, No 1): Table of Contents
- Editor's Memo
The 5th World Symposium on Pulmonary Hypertension, held in Nice, France, in April was a gathering of 1138 delegates from 57 countries converging with one common goal: to advance the field of pulmonary hypertension.
- The World Cup, Olympic Games and PH World Symposium
Many major International sporting events take place every 4 years. Whether one is an avid sports enthusiast or not, one cannot but be touched in some way by the global reach of the events. Perhaps more important than the actual games themselves is the way they mark the passing of time and the link with important other events in our lives.
- The Fifth World Symposium on Pulmonary Hypertension and Robyn J. Barst, MD
The Fifth World Symposium (5th WSPH) on Pulmonary Hypertension was held in Nice, France, from February 27 to March 1, 2013, almost 40 years after the first symposium was convened to develop an understanding of a rare disorder made visible by an epidemic of primary pulmonary hypertension (PH) caused by the prescription of Aminorex.
- Classification of Pulmonary Hypertension
Classification of pulmonary hypertension groups patients with similar pathological findings, hemodynamic profiles, and management strategies. Minor modifications have been made to the current classification system, particularly within Group 1 pulmonary arterial hypertension.
- Pulmonary Arterial Hypertension: Epidemiology and Registries
Registries of pulmonary arterial hypertension (PAH) are important means by which to characterize the presentation and outcome of patients and to provide a basis for predicting the course of the disease. This article summarizes the published conclusions of the World Symposium of Pulmonary Hypertension task force that addressed registries and epidemiology of PAH.
- Insights From the Fifth World Health Organization Symposium Working Group: Definitions and Diagnosis of Pulmonary Hypertension
During the Fifth World Symposium on Pulmonary Hypertension, the working group on diagnosis and assessment was charged with evaluating the definition of pulmonary arterial hypertension (PAH) as it was established at the Fifth World Symposium. The group also covered related topics such as "borderline PAH," exercise-induced PAH, and issues surrounding the measurement of pulmonary capillary wedge pressure (PCWP).
- A Treatment Algorithm for Pulmonary Arterial Hypertension
The treatment algorithm for pulmonary arterial hypertension (PAH) represents graphically a sequence of operations that are needed for the management of patients. The treatment algorithm includes different types of recommendations with varying degrees of scientific evidence. The recommendations are based on information derived from different areas including clinical, hemodynamic, medical, interventional, pharmacological, and regulatory domains.
- How Might Adherence to the Treatment Recommendations of the 2013 Fifth World Symposium on Pulmonary Hypertension Improve Long-Term Outcomes?
A significant expansion in knowledge regarding the diagnosis and treatment of pulmonary arterial hypertension (PAH) within the past 2 decades has transformed a very high-mortality disease without specific therapy for the majority of patients to one with 10 drugs as very effective therapeutic choices.
- Implementation of the PHA Pulmonary Hypertension Care Center Accreditation Program
In the previous issue of Advances in Pulmonary Hypertension, Dr. Studer discussed the emerging evidence suggesting that patients with pulmonary hypertension managed by specialized centers have improved outcomes compared with those without access to comprehensive PH care.
- PHPN: The Many Faces of the PH Professional Network
Our authors for the following Pulmonary Hypertension Professional Network (PHPN) article are both leaders within our organization as well as veterans to the field of pulmonary hypertension. Traci Stewart is a nurse clinician specialist in pulmonary hypertension and cardiomyopathy. Traci is the Immediate Past Chair of the PHPN. Melisa Wilson is a nurse practitioner specializing in pulmonary hypertension and heart failure. Melisa is the current PHPN Chair.